Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Cash Flows

v3.22.2.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (18,796) $ (3,018)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 301 85
Stock-based compensation expense 2,022 940
Amortization of debt issuance costs and discount 799 525
Change in fair value of warrant liabilities (19,712) (16,567)
Change in fair value of derivative liabilities (1,162) (372)
Noncash operating lease expense for right-of-use asset 104 100
Loss on extinguishment of debt 0 2,725
Changes in operating assets and liabilities:    
Prepaid expenses, accounts receivable, inventory, and other (2,248) 1,914
Accounts payable, accrued expenses, other liabilities, and other 4,123 1,214
Net cash used in operating activities (34,569) (12,454)
Cash flows from investing activities:    
Purchase of intangible assets (9) (251)
Net cash used in by investing activities (9) (251)
Cash flows from financing activities:    
Proceeds from common stock issued 47,153 3,431
Payments of offering costs and underwriting discounts and commissions (3,352) (78)
Proceeds from loan payable 5,000 30,000
Payments of loan payable issuance costs (26) (1,253)
Proceeds from employee stock purchase plan issuances 10 9
Net cash provided by financing activities 48,785 32,109
Net increase in cash, cash equivalents, and restricted cash 14,207 19,404
Cash, cash equivalents, and restricted cash at beginning of period 104,702 93,314
Cash, cash equivalents, and restricted cash at end of period 118,909 112,718
Supplemental cash flow information:    
Cash paid for interest 1,930 511
Cash received for interest 194 11
Noncash financing and investing activities:    
Common stock issued for settlement of senior convertible notes 0 7,452
Purchased intangible assets included in accounts payable and accrued expenses 0 321
Deferred offering and issuance costs included in accounts payable and accrued expenses 286 0
Deferred offering costs reclassified to additional-paid-in capital 77 0
Reclass of warrant liability to additional paid in capital 71 298
Reclass of deferred asset associated with issuance of loan payable to debt discount $ 206 $ 390